Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Jaktinib superior to hydroxyurea in myelofibrosis

Jaktinib superior to hydroxyurea in myelofibrosis

07 Jul 2023 bởiStephen Padilla

Jaktinib, a novel JAK and AVCR1 inhibitor, is more effective than hydroxyurea in patients with myelofibrosis, resulting in better spleen response with improved symptom response and less cytopenias, according to the results of a phase III study presented at EHA 2023.

07 Jul 2023
Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19

Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19

07 Jul 2023

In the treatment of patients with mild-to-moderate COVID-19, adding fluvoxamine to favipiravir does not appear to prevent disease progression or improve certain outcomes, according to the results of an open-label study.

07 Jul 2023
More evidence for COVID-19 vaccine safety in kids

More evidence for COVID-19 vaccine safety in kids

05 Jul 2023

COVID-19 vaccines can be safely administered in children, with a recent study showing that out of the numerous health outcomes monitored in near real time, the safety signal identified was for only myocarditis or pericarditis.

05 Jul 2023
ADHD meds emerge as preferred option for reducing self-harm risk in BPD

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

04 Jul 2023 bởiJairia Dela Cruz

For individuals with bipolar disorder (BPD), attention-deficit/hyperactive disorder (ADHD) medications help lower the risk of suicidal behaviour, according to data from a comparative effectiveness research study.

04 Jul 2023